1. All Products
  2. D - Drugs
  3. VALGANCICLOVIR hydrochloride, eq. 450mg base, tab.
Public Pricelist

VALGANCICLOVIR hydrochloride, eq. 450mg base, tab.

https://unicat.msf.org/cat/product/12335
STD DORAVALG4T-

Valid Article

Former Code(s): -X
6.4.3 - Other antivirals
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AB14
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://www.unicat.msf.org/web/image/product.template/568977/image_1920?unique=c224ffd

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

VALGANCICLOVIR

Therapeutic Action

Cytomegalovirus (CMV) nucleoside analogue, DNA polymerase inhibitor

Indications

Treatment of cytomegalovirus retinitis (CMVr)

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Tablets should not be broken or crushed.

Precautions for Use

Avoid direct contact of broken or crushed tablets with the skin or mucous membranes. In case of contact, wash thoroughly with water.

Valganciclovir is considered potentially teratogenic and carcinogenic. Barrier contraceptive precautions should be observed during and after treatment (refer to manufacturer's instructions).

Storage

Below 25ºC